Drug delivery systems of gefitinib for improved cancer therapy: A review
Lung cancer is an uncontrolled and abnormal mass of growing cells with the highest mortality rate in the world. Progressive lung cancer shows a robust resistance to cancer therapy; today no acceptable therapeutic results are achieved with drugs. Gefitinib is an epidermal growth factor receptor tyros...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | OpenNano |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352952023000622 |